Horizon Kinetics Asset Management LLC Biogen Inc. Transaction History

Horizon Kinetics Asset Management LLC

$7.14 Billion
Q4 2024

A detailed history of Horizon Kinetics Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 3,169 shares of BIIB stock, worth $448,191. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,169

Previous 3,040 4.24%

Holding current value

$448,191

Previous $589,000 17.83%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$146.47 - $191.55 $18,894 - $24,709	129 Added 4.24%	3,169 $484,000
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $15,314 - $19,180	-81 Reduced 2.6%	3,040 $589,000
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $424 - $535	2 Added 0.06%	3,121 $672,000
Q4 2023 Feb 15, 2024	SELL	$222.59 - $267.94 $29,159 - $35,100	-131 Reduced 4.03%	3,119 $807,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $128,280 - $146,170	-500 Reduced 13.33%	3,250 $903,000
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $27,990 - $35,971	-125 Reduced 3.23%	3,750 $900,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $12,950 - $20,735	-50 Reduced 1.27%	3,875 $1.34 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $7,045 - $8,254	-29 Reduced 0.73%	3,925 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $10,631 - $16,003	-45 Reduced 1.13%	3,954 $968,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $32,332 - $42,818	-125 Reduced 3.03%	3,999 $1.07 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $34,950 - $44,335	-130 Reduced 3.06%	4,124 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $60,516 - $83,619	-275 Reduced 6.07%	4,254 $1.26 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $21,744 - $24,388	-100 Reduced 2.16%	4,529 $1.05 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $27,411 - $30,215	125 Added 2.78%	4,629 $1.08 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $976,061 - $1.53 Million	4,504 New	4,504 $1.07 Million

Others Institutions Holding BIIB

# of Institutions

1,007

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.

Account

Horizon Kinetics Asset Management LLC Biogen Inc. Transaction History